Energy regulation by the skeleton.
Bones of the skeleton are constantly remodeled through bone resorption by cells called osteoclasts and bone formation by cells called osteoblasts. Both cell types are under multi-hormone control. New research findings demonstrate that bone formation by osteoblasts is negatively regulated by the hormone leptin, which is secreted by adipocytes and acts through the leptin receptor in the central nervous system and ultimately through the sympathetic nervous system. Leptin deficiency leads to increased osteoblast activity and increased bone mass. Reciprocally, expression of the Esp gene, exclusive to osteoblasts, regulates glucose homeostasis and adiposity through controlling the osteoblastic secretion of the hormone-like substance osteocalcin. An undercarboxylated form of osteocalcin acts as a regulator of insulin in the pancreas and adiponectin in the adipocyte to modulate energy metabolism. Osteocalcin deficiency in knockout mice leads to decreased insulin and adiponectin secretion, insulin resistance, higher serum glucose levels and increased adiposity.
Wolf
George
G
Department of Nutritional Sciences and Toxicology, University of California, Berkeley, CA, USA. nutritionreviews@ilsi.org
D001846:Bone Development / Q000502:physiology; D001862:Bone Resorption / Q000378:metabolism; D001842:Bone and Bones / Q000378:metabolism / Q000502:physiology*; D004734:Energy Metabolism / Q000502:physiology*; D006801:Humans; D020738:Leptin / Q000502:physiology*; D009765:Obesity / Q000378:metabolism; D010006:Osteoblasts / Q000378:metabolism*; D015675:Osteocalcin / Q000378:metabolism; D010010:Osteoclasts / Q000378:metabolism*; D010012:Osteogenesis / Q000502:physiology
D020738:Leptin; D015675:Osteocalcin